RENAISSANCE TECHNOLOGIES LLCRENAISSANCE TECHNOLOGIES LLC

Institutional investor · Portfolio as of Q1 2021

Top Holdings3,258 positions

Checking export access…
Activity:
NVONVO
ADR

NOVO-NORDISK A S

24.8M$1.7B2.1%$22.67+31.91%
7 qtrssince 2019-Q3
Decreased
0

VERISIGN INC

4.9M$967.6M1.2%$185.27+5.37%
7 qtrssince 2019-Q3
Decreased
0

ZOOM COMMUNICATIONS INC

2.5M$809.9M1.0%$216.52+44.64%
5 qtrssince 2020-Q1
Increased
53

MONSTER BEVERAGE CORP NEW

8M$724.8M0.9%$29.28+55.56%
7 qtrssince 2019-Q3
Decreased
0

TARGET CORP

3.6M$710.3M0.9%$91.32+84.38%
7 qtrssince 2019-Q3
Decreased
0
3.3M$704.2M0.9%——
7 qtrssince 2019-Q3
Decreased
0
BIDUBIDU
ADR

BAIDU INC

3.2M$697.2M0.9%$113.15+92.27%
7 qtrssince 2019-Q3
Decreased
0

PALO ALTO NETWORKS INC

2.1M$664.5M0.8%$33.97+58.00%
7 qtrssince 2019-Q3
Decreased
0

KROGER CO

17.2M$618.1M0.8%$27.31+17.08%
7 qtrssince 2019-Q3
Decreased
0

FRANCO NEV CORP

4.8M$606.1M0.8%$93.78+27.28%
7 qtrssince 2019-Q3
Decreased
0
VODVOD
ADR

VODAFONE GROUP PLC

32.3M$595.5M0.7%$12.08+4.20%
7 qtrssince 2019-Q3
Decreased
0

MOLINA HEALTHCARE INC

2.5M$576.5M0.7%$109.72+113.05%
7 qtrssince 2019-Q3
Decreased
0

ABIOMED INC

1.8M$567.4M0.7%——
7 qtrssince 2019-Q3
Decreased
0

TESLA INC

827,381$552.6M0.7%$217.65+2.29%
7 qtrssince 2019-Q3
Increased
71

BIOGEN INC

1.9M$542.2M0.7%$237.70+17.69%
7 qtrssince 2019-Q3
Decreased
0

UNITED THERAPEUTICS CORP DEL

3.2M$536.5M0.7%$82.19+103.52%
7 qtrssince 2019-Q3
Decreased
0

HERSHEY CO

3.4M$531.6M0.7%$128.45+7.50%
7 qtrssince 2019-Q3
Decreased
0

VERTEX PHARMACEUTICALS INC

2.4M$515.8M0.6%$178.36+20.48%
7 qtrssince 2019-Q3
Decreased
0
ALXNALXNDelisted

ALEXION PHARMACEUTICALS INC

3.3M$508.9M0.6%——
7 qtrssince 2019-Q3
Decreased
0

F5 INC

2.4M$500.1M0.6%$139.96+49.05%
7 qtrssince 2019-Q3
Decreased
0
$80.4B
AUM
3,258
Positions
Q1 2021
Filing
HI score · 2.5/5
Quarterly 13F Value Change
+10%Q4'19$130.1B-21%Q1'20$103B+13%Q2'20$115.8B-14%Q3'20$100.2B-8%Q4'20$92.1B-13%Q1'21$80.4B
Activity profile
$ moved · Q1'21
New16%Increased20%Decreased50%Exited14%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.0 years
<1Q7%1-4Q16%1-2Y78%2Y+0%

RENAISSANCE TECHNOLOGIES LLC manages $80.4B across 3258 positions as of Q1 2021. Top holdings: NVO (2.1%), VRSN (1.2%), ZM (1.0%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2.5/5.0.

Q1 2021 Summary

Active quarter - 622 new positions, 706 exits, 1067 increased. Top move: TSLA (INCREASED, conviction 71). Portfolio: $80.4B across 3258 positions.

Top holdings by portfolio weight

Total AUM$80B
NVO2.08%
VRSN1.20%
ZM1.01%
MNST0.90%
TGT0.88%
TEAMN0.88%
BIDU0.87%
PANW0.83%
KR0.77%
FNV0.75%
Other0.74%

Portfolio allocation by GICS sector

Sectors11
Healthcare15.83%
Unknown15.39%
Technology14.49%
Consumer Cyclical9.92%
Communication Services9.86%
Consumer Defensive9.43%
Financial Services7.04%
Industrials6.83%
Basic Materials4.65%
Real Estate2.62%
Other3.95%

Behavioral investing profile

Checking access…
Diversified Scout- primarily Healthcare, Unknown, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L44
Conviction37
Concentration18
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
ACRVACRVACRIVON THERAPEUTICS INC
Q4 2024 → Q2 2026+712,963 shares+$1M
7Q
CHGGCHGGCHEGG INC
Q4 2024 → Q2 2026+2M shares+$936,762
7Q
CRCTCRCTCRICUT INC
Q4 2024 → Q2 2026+333,411 shares+$57,703
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used